Self-renewal versus lineage commitment of embryonic stem cells: protein kinase C signaling shifts the balance.
Debasree Dutta, Soma Ray, Pratik Home, Melissa Larson, Michael W Wolfe, Soumen Paul
Index: Stem Cells 29 , 618-28, (2011)
Full Text: HTML
Abstract
The intricate molecular mechanisms that regulate ESC pluripotency are incompletely understood. Prior research indicated that activation of the Janus kinase-signal transducer and activator of transcription (STAT3) pathway or inhibition of extracellular signal-regulated kinase/glycogen synthase kinase 3 (ERK/GSK3) signaling maintains mouse ESC (mESC) pluripotency. Here, we demonstrate that inhibition of protein kinase C (PKC) isoforms maintains mESC pluripotency without the activation of STAT3 or inhibition of ERK/GSK3 signaling pathways. Our analyses revealed that the atypical PKC isoform, PKCζ plays an important role in inducing lineage commitment in mESCs through a PKCζ-nuclear factor kappa-light-chain-enhancer of activated B cells signaling axis. Furthermore, inhibition of PKC isoforms permits derivation of germline-competent ESCs from mouse blastocysts and also facilitates reprogramming of mouse embryonic fibroblasts toward induced pluripotent stem cells. Our results indicate that PKC signaling is critical to balancing ESC self-renewal and lineage commitment.Copyright © 2011 AlphaMed Press.
Related Compounds
Related Articles:
Alpha-lipoic acid activates eNOS through activation of PI3-kinase/Akt signaling pathway.
2015-01-01
[Vascul. Pharmacol. 64 , 28-35, (2015)]
2015-08-01
[Mol. Pharmacol. 88 , 326-34, (2015)]
Deficiency of Factor VII activating protease alters the outcome of ischemic stroke in mice.
2015-04-01
[Eur. J. Neurosci. 41(7) , 965-75, (2015)]
2014-09-01
[Am. J. Physiol. Heart Circ. Physiol. 307(5) , H689-700, (2014)]
Deciphering combinations of PI3K/AKT/mTOR pathway drugs augmenting anti-angiogenic efficacy in vivo.
2014-01-01
[PLoS ONE 9(8) , e105280, (2014)]